• Donate
  • Contact
Canadian Association of Pompe
  • Home
  • About Us
    • Personal Stories
    • Newsletter
  • About Pompe
  • Blog
  • Links
  • Connections
Select Page
Genzyme Study of Myozyme® for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints

Genzyme Study of Myozyme® for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints

by CAP | Dec 13, 2007 | Press Releases

Recent Posts

  • April 15, A Day of Reflection
  • International Pompe Day – Moving On with Pompe!
  • Audentes Therapeutics’ “Be Bold for Courageous Patients” Program to Support Patients Living with Rare Diseases
  • Amicus Therapeutics establishes a 75,000 sq. ft. Gene Therapy Center of Excellence
  • Amicus Therapeutics Receives Breakthrough Therapy Designation for Pompe Treatment
  • Terms
  • Privacy

Copyright © 2006 - 2019 Canadian Association of Pompe | Developed by PacificByte

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok